Ciprofloxacin Hydrochloride and Hydrocortisone Otic Suspension/Drops shortage
To Be Discontinued 1 presentations · 1 manufacturers · first FDA posting Oct 30, 2026 · last update Oct 30, 2026
Availability: Not stated 1
Manufacturers: Sandoz Inc.
Stated reasons (per FDA): Not stated (FDA did not give a reason)
More info: FDA Drug Shortages Database · ASHP drug shortages list (search there for this drug)
Presentations
| Presentation | Availability | FDA dates |
|---|---|---|
| Cipro, Otic Suspension/Drops, 0.2% base, 1% (NDC 66758-087-70) Sandoz Inc. FDA note: Discontinuation of the manufacturing of NDC 66758-087-70. Authorized generic is available under new NDC 0781-6218-70 | Not stated To Be Discontinued | Updated Oct 30, 2026 First posted Oct 30, 2026 Discontinued Oct 30, 2026 |